NTRA
Price
$168.25
Change
+$0.37 (+0.22%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
23.09B
68 days until earnings call
VCYT
Price
$30.34
Change
+$0.39 (+1.30%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
2.39B
74 days until earnings call
Interact to see
Advertisement

NTRA vs VCYT

Header iconNTRA vs VCYT Comparison
Open Charts NTRA vs VCYTBanner chart's image
Natera
Price$168.25
Change+$0.37 (+0.22%)
Volume$10.79K
Capitalization23.09B
Veracyte
Price$30.34
Change+$0.39 (+1.30%)
Volume$35.03K
Capitalization2.39B
NTRA vs VCYT Comparison Chart in %
Loading...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRA vs. VCYT commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Buy and VCYT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (NTRA: $167.88 vs. VCYT: $29.95)
Brand notoriety: NTRA and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NTRA: 59% vs. VCYT: 64%
Market capitalization -- NTRA: $23.09B vs. VCYT: $2.36B
NTRA [@Medical Specialties] is valued at $23.09B. VCYT’s [@Medical Specialties] market capitalization is $2.36B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 5 bullish TA indicator(s).

  • NTRA’s TA Score: 5 bullish, 6 bearish.
  • VCYT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а +3.66% price change this week, while VCYT (@Medical Specialties) price change was +1.77% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.31%. For the same industry, the average monthly price growth was +7.89%, and the average quarterly price growth was +7.74%.

Reported Earning Dates

NTRA is expected to report earnings on Nov 05, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Specialties (-0.31% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($23.1B) has a higher market cap than VCYT($2.39B). NTRA YTD gains are higher at: 6.052 vs. VCYT (-24.369). VCYT has higher annual earnings (EBITDA): 52M vs. NTRA (-211.86M). NTRA has more cash in the bank: 1.02B vs. VCYT (321M). VCYT has less debt than NTRA: VCYT (50.6M) vs NTRA (196M). NTRA has higher revenues than VCYT: NTRA (1.96B) vs VCYT (479M).
NTRAVCYTNTRA / VCYT
Capitalization23.1B2.39B968%
EBITDA-211.86M52M-407%
Gain YTD6.052-24.369-25%
P/E RatioN/A89.24-
Revenue1.96B479M410%
Total Cash1.02B321M317%
Total Debt196M50.6M387%
FUNDAMENTALS RATINGS
NTRA vs VCYT: Fundamental Ratings
NTRA
VCYT
OUTLOOK RATING
1..100
2465
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
39100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4554
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (60) in the Biotechnology industry is in the same range as VCYT (73). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

NTRA's Profit vs Risk Rating (39) in the Biotechnology industry is somewhat better than the same rating for VCYT (100). This means that NTRA’s stock grew somewhat faster than VCYT’s over the last 12 months.

NTRA's SMR Rating (100) in the Biotechnology industry is in the same range as VCYT (100). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

NTRA's Price Growth Rating (45) in the Biotechnology industry is in the same range as VCYT (54). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

NTRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VCYT (100). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRAVCYT
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QIACX52.62N/A
N/A
Federated Hermes MDT All Cap Core IS
TRMCX33.10N/A
N/A
T. Rowe Price Mid-Cap Value
TRPWX23.58N/A
N/A
Nuveen Quant Mid Cap Growth R6
HNVIX36.62N/A
N/A
Heartland Value Plus Institutional
STRNX58.68N/A
N/A
Sterling Capital MdCp Relatv Val C

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+4.68%
NTLA - VCYT
69%
Closely correlated
+1.58%
VCEL - VCYT
60%
Loosely correlated
N/A
AXON - VCYT
58%
Loosely correlated
+1.59%
DNA - VCYT
57%
Loosely correlated
-1.46%
ABCL - VCYT
55%
Loosely correlated
-1.15%
More